Coronary heart disease is an important source of mortality and morbidity among kidney
transplantation and liver transplantation candidates and recipients and is driven by …

Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a
challenging and multisystem disease that has a high socioeconomic impact. NAFLD/NASH …

The first human orthotopic liver transplantation (LT) in Europe was performed by Sir Roy
Calne in Cambridge in 1968 [1], only one year after the first successful human liver …

Liver transplant (LT) candidates today are older, have greater medical severity of illness,
and have more cardiovascular comorbidities than ever before. In addition, there are specific …

Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common
indications for liver transplantation (LT), particularly in candidates older than 65 years …

Current American College of Cardiology/American Heart Association guidelines caution that
preoperative noninvasive cardiac tests may have poor predictive value for detecting …

Despite the rapidly increasing prevalence of obesity in the transplant population, the optimal
management of obese liver transplant candidates remains undefined. Setting strict body …

Improvements in the management of patients undergoing liver transplantation (LT) have
resulted in a significant increase in survival in recent years. Cardiac disease is now the …

An aging population has prompted us to evaluate the indications of liver transplantation (LT)
in elderly patients more frequently. In this review, we summarize the short-and long-term …

Cardiovascular events have a major impact on overall outcomes after liver transplantation.
Today's transplant patients are older than those in the past and therefore are more likely to …